Judge Dismisses Donald Trump's Lawsuit Against Bob Woodward, Simon & Schuster And Paramount Global
In his 2023 lawsuit, Trump had claimed that he had a copyright and contract interest in the audio recordings, interviews which were initially used in Woodward's book Rage, a bombshell that was published in 2020. The audiobook, The Trump Tapes, was released in 2022.
More from Deadline
Donald Trump Files Suit Against Rupert Murdoch, Dow Jones Over Wall Street Journal's Jeffrey Epstein Story
Adam Schiff Talks Of Donald Trump's "Climate Of Fear" In 'Late Show' Guest Appearance; Senate Democrats Raise Questions Of CBS Cancellation - Update
Late-Night TV Is On The Precipice After CBS Axes Stephen Colbert; Insiders Lament "End Of An Era"
U.S. District Judge Paul Gardephe ruled, among other things, that Trump's legal claim does not 'plausibly allege' that he was the joint author of The Trump Tapes or has a copyright interest in them. Trump had claimed that even though he played no role in coming up with the questions, he had a copyright interest in the responses, the judge noted.
The judge wrote that 'The Supreme Court has instructed, under the Copyright Act, 'the author is the party who actually creates the work, that is, the person who translates an idea into a fixed, tangible expression entitled to copyright protection.''
Trump had cited a Feb. 28, 2023 copyright registration he obtained, where he was designated as the joint author with Woodward. But the judge wrote that 'while copyright registration may constitute prema facie evidence of ownership, where there are conflicting and adverse copyright registrations, the Copyright Office does not resolve the competing claims, and courts are called upon to make 'an independent determination of copyright ownership.' Woodward and Simon & Schuster had a copyright registration from Feb. 23, 2023.
The judge will allow Trump to amend his complaint, with a deadline of Aug. 18. But he wrote that he found it 'unlikely' that Trump would be able to plead a 'plausible' copyright interest in The Trump Tapes.
Paramount Global sold Simon & Schuster to KKR in 2023, but the company remained a defendant in the case.
Trump went on to sue Paramount Global shortly before the 2024 election, over the way that CBS News' 60 Minutes edited an interview with Kamala Harris. Paramount Global reached a $16 million settlement with Trump earlier this month, even though its attorneys had previously called the president's lawsuit without merit. The company is seeking Trump administration approval of its merger with Skydance.
Best of Deadline
Streamer Subscription Prices And Tiers – Everything To Know As Costs Rise And Ads Abound (Hello, Peacock) - Update
'Stick' Release Guide: When Do New Episodes Come Out?
'Stick' Soundtrack: All The Songs You'll Hear In The Apple TV+ Golf Series
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
AstraZeneca unveils $50 billion US investment as pharma tariff threat looms
By Maggie Fick and Ahmed Aboulenein WASHINGTON (Reuters) -AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on Monday, the latest big investment by a pharmaceutical company reacting to President Donald Trump's tariff policy. The investment will fund a new drug manufacturing facility in Virginia and expand research and development (R&D) and cell therapy manufacturing in Maryland, Massachusetts, California, Indiana and Texas, it said in a statement. It will also upgrade the Anglo-Swedish drugmaker's U.S. clinical trial supply network and support ongoing investment in novel medicines. On Monday, AstraZeneca said the expansion supports its ambition to reach $80 billion in annual revenue by 2030, with half coming from the U.S. The U.S. accounted for more than 40% of AstraZeneca's annual revenue in 2024, and the company had been prioritising the market - the world's largest, worth $635 billion - before Trump's return to office. The move to scale up its U.S. footprint is the latest by a drugmaker as Trump threatens to impose import tariffs on the industry and seeks to boost domestic manufacturing. The sector has historically been spared from trade disputes. Trump has called on pharma companies to make more of the medicines they sell in the U.S. within the country, rather than importing active ingredients or finished medicines. CEO Pascal Soriot announced the plans in Washington. U.S. Commerce Secretary Howard Lutnick's department is leading a probe into pharmaceutical imports that could pave the way for new tariffs. "For decades Americans have been reliant on foreign supply of key pharmaceutical products. President Trump and our nation's new tariff policies are focused on ending this structural weakness," said Lutnick in a statement issued by AstraZeneca. While Trump has repeatedly threatened tariffs on the sector, he signalled earlier this month that companies would be given a year to 18 months to "get their act together" before any levies take effect. The company said that the timing and location of the announcement was linked to the U.S. policy environment, though some of the spending would have occurred regardless so that the infrastructure for future medicines was in place. The pledge is in addition to the $3.5 billion in investments the company announced in November 2024, the statement said. PLEDGES The $50 billion pledge matches the commitment announced by Swiss rival Roche in April and exceeds new spending plans unveiled this year by Eli Lilly & Co, Johnson & Johnson, Novartis, and Sanofi. Also present at the announcement was Virginia State Governor Glenn Youngkin, a vocal Trump ally who has defended the administration's tariff policies. The new Virginia facility - the company's largest single manufacturing investment - will produce active ingredients for AstraZeneca's experimental weight-loss medicines, including its oral GLP-1 candidate and an oral PCSK9 inhibitor for cholesterol management, it said. The company said the investment could create tens of thousands of new jobs, but declined to give specifics. It employs about 18,000 people in the U.S. and has a global workforce of about 90,000. The effort to strengthen its U.S. ties comes after years of criticism of the UK business investment climate. In January it scrapped plans to invest 450 million pounds ($607.1 million) in its vaccine manufacturing plant in northern England, citing a cut in government support. Earlier this month, The Times reported the company was considering moving its stock market listing from London, where it is the exchange's most valuable company worth 159 billion pounds, to the U.S. The company declined to comment. The company rejoined the leading U.S. drug lobby group earlier this year, roughly two years after leaving it. ($1 = 0.7415 pounds) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11 minutes ago
- Yahoo
Investigators exploring whether grenades found at apartment caused blast that killed 3 LA deputies
APTOPIX Training Facility Exposion LOS ANGELES (AP) — Authorities are looking into whether grenades recovered from a Santa Monica apartment complex caused an explosion last week at a Los Angeles County Sheriff's Department training facility that killed three members of its arson and explosives unit. Investigators served a search warrant Monday morning at an address in the Marina del Rey neighborhood. The department didn't say what, if anything, was found as detectives chase leads following the deadly blast early Friday at the Biscailuz Training Facility. Officials said they are exploring whether there may be a connection to the discovery on Thursday of grenades at an apartment complex in Santa Monica, a few miles (kilometers) north of Marina del Rey. The three members of the arson and explosives team responded that day to assist local police. Los Angeles County Sheriff Robert Luna said the deaths marked the department's worst loss of life in a single incident since 1857, when four officers were killed by gunfire. Those killed Friday were identified by the department as Detective Joshua Kelley-Eklund, Detective Victor Lemus and Detective William Osborn. They served 19, 22 and 33 years in the department respectively, Luna said. Luna said Friday that it took more than four hours to render the scene safe and the deaths were being investigated by the department's homicide detectives, with the assistance of the FBI and the Bureau of Alcohol, Tobacco, Firearms and Explosives. No one else was injured, he said. The sheriff said the arson and explosives team undergoes in-depth training and responds to more than 1,000 calls a year. Solve the daily Crossword
Yahoo
11 minutes ago
- Yahoo
Federal agents in Miami arrest a prominent Haitian businessman and once presidential hopeful
SAN JUAN, Puerto Rico (AP) — Federal agents in Miami have arrested Pierre Réginald Boulos, a well-known Haitian businessman, doctor and former presidential hopeful. The arrest occurred at Boulos' home in South Florida late last week, a person familiar with the arrest said Monday. Boulos was born in the United States but renounced his citizenship to run for president of Haiti in recent years. He obtained his U.S residency last year under the Biden administration. Boulos, who previously has denied a flurry of corruption allegations, is the most well-known Haitian arrested to date by agents with U.S. Immigration and Customs Enforcement. It wasn't immediately clear why Boulos was arrested. ICE did not return a message seeking details. An attorney for Boulos could not be immediately reached for comment. Boulos was being held at Krome North Service Processing Center in Miami, a detention center that Human Rights Watch said in a recent report is one of three in Florida that are grossly over capacity and 'flagrantly violate international human rights standards.' Boulos founded several businesses while in Haiti, where he served as president of the National Chamber of Commerce and Industry. In 2019, he created the Third Way Movement, a political party in contrast to the "shameless elite and the unscrupulous politicians who are working to bog down the country and increase the suffering of the people,' he said at the time, according to local media. The party promptly stated it would seek "a historic political compromise that would facilitate the negotiated departure from power of Jovenel Moïse.' Boulos visited Haiti's central region in August 2019 as he rallied for support. 'I am part of the system that must be destroyed," he was quoted as saying by Le Nouvelliste newspaper. 'I know how to destroy it.' Moïse served as president from 2017 until he was gunned down at his private residence in July 2021. Dozens of suspects were arrested, including seventeen former Colombian soldiers who are still being interrogated by Haitian authorities. Court documents have stated that those involved in the plot included Christian Emmanuel Sanon, a pastor, doctor and failed businessman who envisioned himself as Haiti's new leader. Elections have not been held since Moïse was killed. Gang violence surged in the political vacuum that ensued, and Boulos soon returned to the U.S. The arrest comes as the Trump administration seeks to end legal protections for hundreds of thousands of Haitians after announcing it would revoke such protections for those who arrived in the U.S. under a humanitarian parole program. Rod Joseph, a Haitian-American running for U.S. Congress, said he has been working with the administration to avoid deporting people 'just for the fun of it.' 'If the president goes after criminals, no one is against that,' he said over the phone on Monday. 'But if you deport someone who doesn't commit any crime who's here seeking a better life, this is when we start having issues with the practice.' Dánica Coto, The Associated Press Erreur lors de la récupération des données Connectez-vous pour accéder à votre portefeuille Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données
